ca.reuters.com

ca.reuters.com
Share

ca.reuters.com

 •  February 14

(Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.TA: Quote) is looking to buy more shares in Mylan NV (MYL.O: Quote), positioning itself for a possible legal challenge to the generics drugmaker that has spurned its takeover bid, people familiar with the matter said. The strategy is a sign of Teva's commitment to its $40 billion bid for Mylan,...

ca.reuters.com

 •  February 14

LONDON (Reuters) - Drugmaker Shire (SHP.L: Quote) said on Tuesday it was seeking to buy Baxalta BXLT.N, a company spun-off by Baxter International (BAX.N: Quote) last month, for $30 billion to forge the leading global specialist in rare diseases. The London-listed group went public with its approach after the U.S. firm turned it down during private...

ca.reuters.com

 •  February 14

NEW YORK (Reuters) - Leading global pharmaceutical companies have started to view their vast portfolios of older, established prescription drugs as vehicles for raising large sums of cash to fuel development of new medicines with far higher profit margins. France's Sanofi (SASY.PA: Quote) and U.S. drugmakers Merck & Co (MRK.N: Quote) and Abbott...